Details of the Drug Reposition

General Information of This Drug (ID: DM4I1JP)

• Drug Name: Polyethylene glycol (DM4I1JP)
• Synonyms: ETHYLENE GLYCOL; Ethane-1,2-diol; 1,2-ethanediol; 107-21-1; glycol; monoethylene glycol; 1,2-Dihydroxyethane; 2-hydroxyethanol; Glycol alcohol; polyethylene glycol; Ethylene alcohol; Macrogol; Fridex; Tescol; Ethylene dihydrate; Norkool; Macrogol 400 BPC; Dowtherm SR 1; Zerex; Ucar 17; Lutrol-9; ethyleneglycol; ethanediol; Aethylenglykol; Polyethylene glycol 200; Glycol, ethylene-; 1,2-Ethandiol; Glycols, polyethylene; Caswell No. 441; Ethylenglycol; Lutrol; Aethylenglykol [German]; Polyethylene glycol 600; 146AR; UNII-FC72KVT52F
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

2 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Keratoconjunctivitis sicca	DISNOENH	9A79	Discontinued in Phase 2	[1]
Constipation	DISRQXWI	DD91.1	Discontinued in Phase 2	[2]

References

• [1] Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients
• [2] Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure